Your browser doesn't support javascript.
loading
Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical Practice.
Khanna, Dinesh; Lescoat, Alain; Roofeh, David; Bernstein, Elana J; Kazerooni, Ella A; Roth, Michael D; Martinez, Fernando; Flaherty, Kevin R; Denton, Christopher P.
Affiliation
  • Khanna D; University of Michigan, Ann Arbor.
  • Lescoat A; University of Michigan, Ann Arbor, and University of Rennes 1, Centre Hospitalier Universitaire Rennes, INSERM, École des Hautes Études en Santé Publique, and Institut de Recherche en Santé, Environnement et Travail, Rennes, France.
  • Roofeh D; University of Michigan, Ann Arbor.
  • Bernstein EJ; Columbia University Irving Medical Center, New York, New York.
  • Kazerooni EA; University of Michigan, Ann Arbor.
  • Roth MD; University of California, Los Angeles.
  • Martinez F; New York University and Cornell University, New York.
  • Flaherty KR; University of Michigan, Ann Arbor.
  • Denton CP; University College of London, London, UK.
Arthritis Rheumatol ; 74(1): 13-27, 2022 01.
Article in En | MEDLINE | ID: mdl-34313399
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Lung Diseases, Interstitial / Antibodies, Monoclonal, Humanized / Indoles Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Arthritis Rheumatol Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Lung Diseases, Interstitial / Antibodies, Monoclonal, Humanized / Indoles Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Arthritis Rheumatol Year: 2022 Type: Article